Dr. Farzad Sedaghat presented a virtual Grand Rounds session explaining the extensive diagnostic testing required for bladder and upper-tract urothelial carcinoma (UTUC) [1].
Understanding these protocols is critical because the high volume of repeated scans, including MRIs and ultrasounds, often creates confusion and anxiety for patients and clinicians navigating the treatment pathway.
Sedaghat, who serves as the Section Chief of Ultrasound and an Assistant Professor of Radiology and Radiological Science, led the presentation titled “It’s Endless: Tests, Scans, MRI’s, Ultrasounds and more Tests” [1]. The session was hosted by Johns Hopkins Medicine as part of the GBCI Virtual Grand Rounds [1].
The presentation focused on the purpose, meaning, and interpretation of various diagnostic tools used specifically for bladder and UTUC cases [1]. Sedaghat said he aimed to demystify the process by explaining why multiple modalities are necessary to monitor the disease and evaluate treatment efficacy [1].
By breaking down the role of each specific scan, the session provided a framework for better communication between medical providers and their patients [1]. The goal was to clarify how different tests complement one another to provide a comprehensive view of the cancer's progression, or lack thereof, over time [1].
This educational effort highlights the complexity of urothelial carcinoma management, where a single test is rarely sufficient to determine the full scope of the disease [1].
“The session was hosted by Johns Hopkins Medicine as part of the GBCI Virtual Grand Rounds.”
The emphasis on demystifying diagnostic 'endlessness' suggests a recognized gap in patient communication regarding oncology workflows. By standardizing the explanation of why repeated imaging is necessary, providers can reduce patient distress and improve adherence to rigorous monitoring schedules required for urothelial carcinomas.
